{"id":"589ef435-25b7-897b-0fb5-86bb12b0dbbc","Content":[{"Language":"en-US","Content":"[$BOX]\n\t[$CELL]\n\t\t[$BLOCK]\n\n\t\t\t<h3>Cross-reactivity in blood transfusions</h3>\n\t\t\t<p>When an antibody and its target antigen interact with each other, the red blood cells clot together and massive hemolysis occurs(i.e. if an anti-A-antibody crosses an A antigen). This is called <strong>cross reactivity</strong>.</p>\n\t\t\t<p>The clots and fragments of red blood cells can form a barrier and obstruct the blood vessels of the kidneys, lungs, heart, or brain. This leads to damage and/or necrosis of the affected tissues, which could lead to death.</p>\n\t\t\t<p>Cross reactivity can be prevented by ensuring that the blood groups of the donor and the recipient are compatible (matching). In clinical practice, only the antigens on the blood cells of the donor are important. The antibodies in the donor plasma are of lesser importance in determining the compatibility.</p>\n\n\t\t[$/BLOCK]\n\t[$/CELL]\n\t[$CELL]\n\n\t\t[$IMG(\"/media/Images/shutterstock_143620354.jpg\";450,300)]\n\n\t[$/CELL]\n[$/BOX]","Name":"Cross-reactivity in blood transfusions"}]}